Fewer <scp>COVID‐19</scp> Neurological Complications with Dexamethasone and Remdesivir

202230 citationsJournal Articlehybrid Open Access

Authors

Alexander Grundmann · University Hospital Southampton NHS Foundation Trust

Chieh‐Hsi Wu · University of Southampton

Marc Hardwick · University Hospital Southampton NHS Foundation Trust

J. Kenneth Baillie · Roslin Institute

Peter Openshaw · Imperial College Healthcare NHS Trust

Malcolm G. Semple · University of Liverpool

Dankmar Böhning

Abstract

Treatment with dexamethasone, remdesivir, or both in patients hospitalized with COVID-19 was associated with a lower frequency of neurological complications in an additive manner, such that the greatest benefit was observed in patients who received both drugs together. ANN NEUROL 2023;93:88-102.

Topics & Keywords

Long-Term Effects of COVID-19 COVID-19 Clinical Research Studies Intensive Care Unit Cognitive Disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of Neurology

Volume 93, Issue 1, pp. 88-102

DOI: 10.1002/ana.26536

Field-Weighted Citation Impact: 3.61